News
TCRT
1.940
+1.04%
0.020
Weekly Report: what happened at TCRT last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at TCRT last week (0706-0710)?
Weekly Report · 07/13 10:25
Weekly Report: what happened at TCRT last week (0629-0703)?
Weekly Report · 07/06 10:29
Alaunos Reports New Preclinical Liver Data for ALN1003
TipRanks · 06/29 12:59
Alaunos’ ALN1003 Shows Statistically Significant Reduction In Liver Weight Independent Of Body Fat In Preclinical Analysis
Benzinga · 06/29 12:36
Alaunos reports new preclinical analysis showing ALN1003 lowers liver weight in 48-day DIO mouse study
PUBT · 06/29 12:31
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/29 12:05
Weekly Report: what happened at TCRT last week (0622-0626)?
Weekly Report · 06/29 10:23
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
Barchart · 06/29 07:35
Weekly Report: what happened at TCRT last week (0615-0619)?
Weekly Report · 06/22 10:34
Weekly Report: what happened at TCRT last week (0608-0612)?
Weekly Report · 06/15 10:34
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 06/11 21:05
Weekly Report: what happened at TCRT last week (0601-0605)?
Weekly Report · 06/08 10:29
Weekly Report: what happened at TCRT last week (0525-0529)?
Weekly Report · 06/01 10:35
Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX
NASDAQ · 05/28 08:11
Alaunos Therapeutics reports metabolic improvements with ALN1003 in studies
TipRanks · 05/26 16:02
Alaunos Reports Positive Preclinical Metabolic Data for ALN1003
TipRanks · 05/26 15:30
Alaunos Therapeutics Reports Preclinical Results For ALN1003 Showing Weight Loss, Improved Insulin Sensitivity, And Better Liver Health In Obese Mouse Studies
Benzinga · 05/26 15:05
Alaunos publishes investor presentation on ALN1003 preclinical data
PUBT · 05/26 15:01
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
Barchart · 05/26 10:01
More
Webull provides a variety of real-time TCRT stock news. You can receive the latest news about Alaunos Therapeutics, Inc through multiple platforms. This information may help you make smarter investment decisions.
About TCRT
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.